Short Title:
Responsible HRP Element:
Human Health Countermeasures
|
Supporting Org(s):
|
| International Space Station Medical Project |
|
Funding Status:
Planned - Task expected to be within budget
|
Procurement Mechanism(s):
|
| NASA Research Announcement |
|
Aims:
Determine if emerging drug (tbd) can prevent skeletal deconditioning as characterized by bone measures (bone mass and bone turnover markers) in astronauts.
Integration/Unique Aspects:
Flight Resources
| Number of Subjects
|
12
|
| When are operations required?
|
Pre/Post
|
| When is an approved proposal expected?
|
10/2/2017
|
|
Frequency and type of in-flight sessions:
N/A
|
|
Type of in-flight sessions:
N/A
|
|
Type of in-flight sample collection:
N/A
|
|
Hardware/Software Requirements:
N/A
|
|
BDC Requirements:
|
Category:
Countermeasures
Subcategory:
Prototype Hardware, Pharmaceutical, Nutritional Supplement
Description:
Customer:
Space Medicine
Is there a signed Customer-Supplier Agreement?
No
Delivery Milestone:
9/30/2020